Page last updated: 2024-10-29

ketamine and Hemangiosarcoma

ketamine has been researched along with Hemangiosarcoma in 1 studies

Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.

Hemangiosarcoma: A rare malignant neoplasm characterized by rapidly proliferating, extensively infiltrating, anaplastic cells derived from blood vessels and lining irregular blood-filled or lumpy spaces. (Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Estrin, JA1
Belani, KG1
Karnavas, AG1
Peterson, BJ1
Leonard, AS1
Buckley, JJ1

Other Studies

1 other study available for ketamine and Hemangiosarcoma

ArticleYear
A new approach to massive blood transfusion during pediatric liver resection.
    Surgery, 1986, Volume: 99, Issue:6

    Topics: Blood Coagulation Tests; Blood Gas Analysis; Blood Transfusion; Body Temperature; Carcinoma, Hepatoc

1986